Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Top UK Pharma & Biotech Shares
Compare up to 10 stocks
Comparison Results
Name | Price | Volume | Analyst Price Target | Analyst Consensus | Smart Score | Market Cap | P/E Ratio | Dividend Yield | Sector | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AstraZeneca | 10938.00p | 2.77M | xxxxxxxxxxxxx | 9 Buy 5 Hold 0 Sell Moderate Buy | £168.14B | 32.23 | 2.19% | Healthcare | |||
 GlaxoSmithKline | 1359.00p | 10.27M | xxxxxxxxxxxxx | 2 Buy 7 Hold 2 Sell Hold | £55.03B | 21.52 | 4.59% | Healthcare | |||
 Hikma Pharmaceuticals | 2086.00p | 345.38K | xxxxxxxxxxxxx | 4 Buy 1 Hold 0 Sell Strong Buy | £4.60B | 19.90 | 3.06% | Healthcare | |||
 HUTCHMED (China) Limited | 234.00p | 49.04K | xxxxxxxxxxxxx | 1 Buy 0 Hold 0 Sell Moderate Buy | £1.90B | -62.44 | ― | Healthcare | |||
 | $3866.00 | 192.11K | xxxxxxxxxxxxx | ― | $4.40B | ― | ― |
Performance Comparison
GB:AZN
AstraZeneca
10,938.00
729.90
7.15%
GB:GSK
GlaxoSmithKline
1,359.00
-137.85
-9.21%
GB:HIK
Hikma Pharmaceuticals
2,086.00
219.21
11.74%
GB:HCM
HUTCHMED (China) Limited
234.00
-6.50
-2.70%
GB:DPH
―
3,866.00
0.00
0.00%
Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.
Pharma & Biotech Stocks Latest News
Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.
Recent Analysts Ratings of Pharma & Biotech Stocks
Most Recent Earnings of Pharma & Biotech Stocks
AstraZeneca
Nov 12, 2024
Sep 01, 2024
145
GlaxoSmithKline
Oct 30, 2024
Sep 01, 2024
28.9
Hikma Pharmaceuticals
Aug 08, 2024
Jun 01, 2024
21.4
HUTCHMED (China) Limited
Jul 31, 2024
Jun 01, 2024
-1.469
―
―
―
―
Pharma & Biotech Stocks - FAQ
Which Pharma & Biotech stocks have a "Strong Buy" analyst rating?
These Pharma & Biotech stocks currently have a "Strong Buy" analyst rating consensus:
Hikma Pharmaceuticals - Strong Buy, based on 5 analyst ratings, 4 Buy, 1 Hold, and 0 Sell.
Are Pharma & Biotech stocks overpriced?
AstraZeneca's stock price is currently 10,938.00p, and its average 12-month price target is 13,668.91p.
GlaxoSmithKline's stock price is currently 1,359.00p, and its average 12-month price target is 1,597.78p.
Hikma Pharmaceuticals's stock price is currently 2,086.00p, and its average 12-month price target is 2,495.00p.
HUTCHMED (China) Limited's stock price is currently 234.00p, and its average 12-month price target is 440.72p.
's stock price is currently 3,866.00, and its average 12-month price target is N/A.
Which Pharma & Biotech stocks pay dividends?
AstraZeneca does not currently pay dividends.
GlaxoSmithKline does not currently pay dividends.
Hikma Pharmaceuticals does not currently pay dividends.
HUTCHMED (China) Limited does not currently pay dividends.
does not currently pay dividends.